General Mills' Benefit psyllium cereal

Package labeling changed to focus on ingredients in cold cereal such as oat bran and psyllium as part of a "heart healthy diet" and not on health claims to reduce cholesterol. General Mills said some consumers were "confused" by "reduces cholesterol" claim into thinking product now had less cholesterol when, in fact, it contains none. Label changes were not a result of FDA scrutiny of cereals with psyllium ("The Pink Sheet" Oct. 2, T&G-12), a spokesperson said. Company is very close to filing a GRAS petition with the agency on psyllium. Redesigned boxes are slated to be on shelves in two to three months. Product is available in one-third of U.S., mainly in Midwest.

More from Archive

More from Pink Sheet

Canada’s HTA Agency Reveals How To Submit AI-Driven Evidence

 

Recognizing that the evidence it receives in applications for health technology assessments will increasingly be informed by artificial intelligence, the CDA-AMC has clarified its expectations for companies that use AI methods in the generation and/or reporting of evidence.

New EU Filings

 

Plozasiran, Arrowhead Pharmaceuticals' treatment for familial chylomicronemia syndrome, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.

DIA Korea: Medical Turmoil, Global Factors Blunt Korea’s Trial Edge

 
• By 

DIA Korea hears how multiple domestic and global factors are affecting the environment for clinical trials in South Korea, and what actions may be taken to address this.